» Articles » PMID: 25110692

The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Aug 12
PMID 25110692
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Chemoattractant receptors are a family of seven transmembrane G protein coupled receptors (GPCRs) initially found to mediate the chemotaxis and activation of immune cells. During the past decades, the functions of these GPCRs have been discovered to not only regulate leukocyte trafficking and promote immune responses, but also play important roles in homeostasis, development, angiogenesis, and tumor progression. Accumulating evidence indicates that chemoattractant GPCRs and their ligands promote the progression of malignant tumors based on their capacity to orchestrate the infiltration of the tumor microenvironment by immune cells, endothelial cells, fibroblasts, and mesenchymal cells. This facilitates the interaction of tumor cells with host cells, tumor cells with tumor cells, and host cells with host cells to provide a basis for the expansion of established tumors and development of distant metastasis. In addition, many malignant tumors of the nonhematopoietic origin express multiple chemoattractant GPCRs that increase the invasiveness and metastasis of tumor cells. Therefore, GPCRs and their ligands constitute targets for the development of novel antitumor therapeutics.

Citing Articles

Cysteine cathepsins and autoimmune diseases: A bidirectional Mendelian randomization.

Wu Y, Li Q, Lou Y, Zhou Z, Huang J Medicine (Baltimore). 2024; 103(43):e40268.

PMID: 39470488 PMC: 11521024. DOI: 10.1097/MD.0000000000040268.


Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment.

Kumari S, Kumar P Front Cell Dev Biol. 2023; 11:1236271.

PMID: 37538397 PMC: 10395518. DOI: 10.3389/fcell.2023.1236271.


Identification and verification of immune-related gene prognostic signature based on ssGSEA for breast cancer.

Chen G, Cao J, Zhao H, Cong Y, Qiao G Cent Eur J Immunol. 2023; 47(2):139-150.

PMID: 36751391 PMC: 9894087. DOI: 10.5114/ceji.2022.118081.


Identification of immune associated potential molecular targets in proliferative diabetic retinopathy.

Gao Y, Xue M, Dai B, Tang Y, Liu J, Zhao C BMC Ophthalmol. 2023; 23(1):27.

PMID: 36658547 PMC: 9854219. DOI: 10.1186/s12886-023-02774-y.


A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs.

Villarreal-Garcia V, Estupinan-Jimenez J, Vivas-Mejia P, Gonzalez-Villasana V, Vazquez-Guillen J, Resendez-Perez D Front Oncol. 2022; 12:980694.

PMID: 36226048 PMC: 9548555. DOI: 10.3389/fonc.2022.980694.


References
1.
Albert S, Riveiro M, Halimi C, Hourseau M, Couvelard A, Serova M . Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma. Head Neck. 2013; 35(12):1819-28. DOI: 10.1002/hed.23217. View

2.
Fusi A, Liu Z, Kummerlen V, Nonnemacher A, Jeske J, Keilholz U . Expression of chemokine receptors on circulating tumor cells in patients with solid tumors. J Transl Med. 2012; 10:52. PMC: 3337808. DOI: 10.1186/1479-5876-10-52. View

3.
Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N . Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer. 2002; 102(3):220-4. DOI: 10.1002/ijc.10705. View

4.
Cho Y, Lee W, Choi S, Kim J, Hong H, Kim S . CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol Rep. 2012; 28(2):689-94. DOI: 10.3892/or.2012.1815. View

5.
Amersi F, Terando A, Goto Y, Scolyer R, Thompson J, Tran A . Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res. 2008; 14(3):638-45. PMC: 2760931. DOI: 10.1158/1078-0432.CCR-07-2025. View